size-exclusion chromatography raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-04-14 and is reviewed periodically as new material appears.
Testing hydrolysate powders typically begins with proximate analysis for moisture, ash, fat, and total nitrogen. Protein content is calculated from nitrogen using a conversion factor, most often Kjeldahl or Dumas combustion. Peptide size distribution is assessed by size-exclusion chromatography, reversed-phase HPLC, or mass spectrometry. Sodium dodecyl sulfate polyacrylamide gel electrophoresis can show residual intact protein bands. Free amino groups may be quantified by colorimetric assays to estimate cleavage extent, though different methods and laboratories are not always directly comparable.
Dry hydrolysate powders are generally stable when kept cool, dry, and sealed, while moisture uptake can cause caking, Maillard browning, and loss of solubility. Higher temperatures accelerate these changes and may alter flavor. Recommended storage conditions often fall between 15 and 25 degrees Celsius with relative humidity below 60 percent. Once reconstituted, liquid hydrolysate solutions support microbial growth and may develop bitterness or haze over time. Packaging in moisture-barrier containers with desiccants helps maintain quality during transport and warehouse storage.
Storage stability depends on moisture, temperature, and exposure to oxygen. Dry hydrolysate powders are hygroscopic and can clump or cake when humidity is high. Moisture also promotes Maillard reactions between peptides and residual lactose, leading to browning and flavor changes. Cool, dry, sealed storage slows these reactions, while prolonged warmth can increase off-flavors and reduce solubility. Stability studies often track color, moisture, free amino groups, and microbial load over time to estimate shelf life.
Quality control includes verifying identity, protein content, degree of hydrolysis, and absence of contaminants. Because hydrolysates are often used in foods and supplements, regulations may treat them as food ingredients rather than drugs. Allergen labeling rules can vary, and highly hydrolyzed products are sometimes considered less allergenic, but this depends on peptide size and clinical testing. Sourcing documents should link each lot to raw whey, enzymes, and processing conditions. Independent verification is useful because analytical results can shift with method and laboratory.
| Property | Value | Notes |
|---|---|---|
| Moisture content | ≤5% typical | Higher moisture promotes caking and browning |
| pH (5% solution) | 6.0–7.5 typical | Varies with hydrolysis and neutralization |
| Ash content | 1–8% | Depends on demineralization and neutralization salts |
| Microbiological limit | Total aerobic count <10^4 CFU/g typical | Specifications vary by grade and market |
| Shelf life | 12–24 months unopened | Cool, dry storage extends stability |
Commercial production begins with whey protein concentrate or isolate dissolved in water. A protease is added under controlled pH and temperature, and the reaction is stopped by heat or pH adjustment once a target degree of hydrolysis is reached. Membrane filtration, often ultrafiltration or diafiltration, removes enzymes and small solutes while retaining peptides. The liquid is then concentrated and spray-dried into a powder. Each step influences peptide length, mineral content, and flavor.
Quality control focuses on degree of hydrolysis, molecular weight distribution, protein content, moisture, ash, and microbial limits. Degree of hydrolysis is commonly calculated from the number of cleaved peptide bonds relative to total peptide bonds. Size-exclusion chromatography and mass spectrometry can describe peptide size ranges, while amino acid analysis quantifies composition. Standard methods from dairy science organizations are often used, though no single method captures every functional property. Results are therefore reported alongside processing conditions.
Hydrolysates are generally stable as dry powders but can absorb moisture and undergo browning during warm storage. The bitter taste of some hydrolysates arises from hydrophobic peptides exposed by cleavage, and it varies with enzyme choice and degree of hydrolysis. Reduced allergenicity is sometimes claimed, but residual IgE-binding peptides may remain, especially in partial hydrolysates. Regulatory frameworks treat extensively hydrolyzed and partially hydrolyzed products differently, and labeling rules vary by country. More research is needed on how specific peptide profiles relate to clinical outcomes.
Quality control for whey protein hydrolysate combines compositional and molecular tests. Protein content is measured by Kjeldahl or Dumas nitrogen determination. Moisture, ash, fat, and lactose are checked with standard food methods. The degree of hydrolysis is estimated by TNBS, OPA, or pH-stat procedures that quantify free amino groups or released protons. Molecular weight distribution is examined by size-exclusion chromatography or SDS-PAGE. These tests describe average peptide size rather than exact peptide sequences, and results depend on standards and calibration.
Advanced peptide profiling uses liquid chromatography coupled with mass spectrometry to identify fragments and assess batch consistency. Amino acid analysis after acid hydrolysis quantifies the building blocks and can reveal deviations from expected composition. Residual enzyme activity may be monitored in products where active enzymes are undesirable. Allergen tests often use immunoassays for beta-lactoglobulin, but hydrolysis can reduce or alter epitope recognition, so negative results do not prove absence of allergenic potential. Physical tests include particle size, bulk density, and reconstitution behavior.
Regulatory and labeling frameworks vary by country. In the United States, whey protein hydrolysate may be regulated as a food ingredient or a dietary supplement ingredient depending on intended use. In the European Union, it falls under general food law, with additional rules for infant formula and foods for special medical purposes. A claim of hypoallergenicity is not established by hydrolysis alone and generally requires clinical evidence. Open questions remain about how degree of hydrolysis relates to bitterness, nitrogen absorption, and residual allergenicity across different products and processing methods.
=== Wound dressings === There are many types of dressings used to treat diabetic foot ulcers, such as absorptive fillers, hydrogel dressings, and hydrocolloids. There is no good evidence that one type of dressing is better than another for diabetic foot ulcers. In selecting dressings for chronic non-healing wounds, it is recommended that the cost of the product be taken into account. Hydrogel dressings may have shown a slight advantage over standard dressings, but the quality of the research is of concern. Dressings and creams containing silver have not been properly studied nor have alginate dressings. Biologically active bandages that combine hydrogel and hydrocolloid traits are available; however, more research needs to be conducted as to the efficacy of this option over others.
== Adverse effects == Although the absorption of betamethasone dipropionate is small, when used for prolonged periods of time (periods exceeding two weeks), or across a large surface area (total use greater than 50 grams per week), it can have adverse effects. One such effect is the ability of the corticosteroid to suppress the hypothalamic–pituitary–adrenal axis. This can lead to a depression in the release of adrenal hormones such as cortisol and adrenocorticotropic hormone, or ACTH. Symptoms of HPA axis suppression are often subtle and variable, but can often be detected using simple blood or urine tests such at ACTH stimulation test or urinary free cortisol. Those at increased risk for HPA axis suppression are those who are more likely to absorb more of the steroid through the skin. These groups include:
=== September === 1 September Kelly Ana Morey, novelist and poet (born 1968) Peter Truscott, cricketer (Canterbury, Wellington, national team) (born 1941). 2 September – David H. Clark, astrophysicist (Rutherford Appleton Laboratory) and science administrator (SERC, EPSRC). 4 September – Maxine Arnold, local politician, Porirua City Councillor (1974–1992), Wellington Regional Councillor (1980–1995), first women elected to a licensing trust (1968) (born 1928). 6 September – Dame Pat Harrison, educationalist and local politician, principal of Queen's High School, Dunedin (1975–1994), University of Otago council member (1983–1994), Otago Regional Councillor (born 1932). 7 September Robin Chadwick, actor (Julius Caesar, The Brothers) (born 1939). John Irwin, psychologist (University of Auckland) (born 1934). 8 September – Tom Phillips, fugitive father who disappeared with his three children between 2021 and 2025. 9 September David Buckingham, physical chemist (Australian National University, University of Otago), Fellow of the Royal Society of New Zealand (since 1980) (born 1936). Charlie Cotton, basketball player (national team) (born 1943). 10 September – Stan Martin, rugby league player (Richmond Rovers) and coach (Whitehaven, Cook Islands, women's national team) (born 1953). 11 September Randall Morton, otolaryngologist (University of Auckland) (born 1947). Graham Young, educator, principal of Tauranga Boys' College (1985–2008).
Hydrophobic interaction chromatography (HIC) can also be used for first and/ or intermediate steps. Selectivity in HIC is independent of running pH and descending salt gradients are used. For HIC, conditioning involves adding ammonium sulfate to the sample to match the buffer A concentration. If HIC is used before IEC, the ionic strength would have to be lowered to match that of buffer A for IEC step by dilution, dialysis or buffer exchange by gel filtration. This is why IEC is usually performed prior to HIC as the high salt elution conditions for IEC are ideal for binding to HIC resins in the next purification step. Polishing is used to achieve the final level of purification required and is commonly performed on a gel filtration column. An extra intermediate purification step can be added or optimization of the different steps is performed for improving purity. This extra step usually involves another round of IEC under completely different conditions. Although this is an example of a common purification protocol for proteins, the buffer conditions, flow rates, and resins used to achieve final goals can be chosen to cover a broad range of target proteins. This flexibility is imperative for a functional purification system as all proteins behave differently and often deviate from predictions.
Sources: en.wikipedia.org
Two hundred and eighty-six scholars, artists, and scientists received Guggenheim Fellowships in 1970. $2,605,000 was disbursed between the recipients, who were chosen from an applicant pool of 2,313. Of the 81 universities represented, University of California, Berkeley had the most winners on its faculty (23), with Harvard University (17) claiming second and University of California, Los Angeles (10) claiming third.
Decreasing heroin purity, competition from increased access to prescription medications, and dissemination of "The Siegfried Method" (a relatively simple and cost-effective method of fentanyl production) were major factors in street suppliers' inclusion of fentanyl in their products. The current, fourth wave, which began in 2016, has been characterized by polysubstance overdose due to synthetic opioids like fentanyl mixed with stimulants such as methamphetamine or cocaine. In 2010, around 0.5% of opioid-related deaths were attributed to mixture with stimulants. This figure increased more than 50-fold by 2021, when about a third of opioid-related deaths, or 34,000, involved stimulant use. In 2017, the U.S. Department of Health and Human Services (HHS) announced a public health emergency due to an increase in the misuse of opioids. The administration introduced a strategic framework called the Five-Point Opioid Strategy, which includes providing access recovery services, increasing the availability of reversing agents for overdose, funding opioid misuse and pain research, changing treatments of people managing pain, and updating public health reports related to combating opioid drug misuse. Studies done in the U.S. from 2010 to 2019 revealed that about 86.6% of people in the U.S. who could have benefited from opioid use disorder treatment were not receiving it. Over the past decade, the uptake of medications for opioid use disorder has increased, but there are still many regions with a prevalence of opioid use disorder and lack of medical support. The U.S.
== Research == Blisibimod, an inhibitor of both soluble and membrane-bound BAFF, has demonstrated similar reductions of B cells in clinical trials and is being investigated in a Phase II clinical study for patients with lupus. BR3-Fc, a recombinant fusion protein built with the extracellular ligand-binding portion of BAFF-R, blocks activation of this receptor by BLyS and is in early-stage pharmaceutical development. Rituximab, an anti-CD20 monoclonal antibody, has been approved for some indications. Ocrelizumab, ofatumumab, and "third-generation" anti-CD20 monoclonals are in development. Other drugs addressing B lymphocyte hyperactivity include atacicept, a recombinant fusion protein that is built with the extracellular ligand binding portion of TACI and blocks activation of TACI by APRIL and BLyS. It failed a Phase II trial for multiple sclerosis.
Sources: en.wikipedia.org
Keep the powder sealed in a cool, dry place away from direct sunlight and strong odors. Typical targets are 15 to 25 degrees Celsius and low relative humidity. After opening, use within the manufacturer's recommended period.
Size-exclusion chromatography and mass spectrometry provide molecular weight or mass information. Electrophoresis can reveal intact protein bands and larger fragments. No single method captures the complete peptide profile.
Not always, because assays and calculation methods differ. Values may reflect free amino groups, pH change, or nitrogen solubility. Comparisons require method details and reference standards.
Common methods quantify free amino groups, pH change, or osmolarity during or after hydrolysis. Each method uses different assumptions and can yield different values for the same sample. For this reason, degree of hydrolysis should be reported with the method used.